Skip to main content
    S

    Serina Therapeutics Inc (SER)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • AMEX

    $1.36
    -0.05 (-3.87%)

    Market Cap: $37.73M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    Serina Therapeutics Inc (SER) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Serina Therapeutics (SER) has a latest price of $1.36 on Nov 17, 2026, 68.0% below its 52-week high of $4.26. Its price fell 66.6% over the past 12 months. The month-end price fell 93.3% over the 5 years through Oct 2026, a compound annual decline of 41.8%.

    Price Chart

    From Nov 2018 to Oct 2026, its highest month-end close was $192.86 in Nov 2018 and its lowest $1.80 in Feb 2026, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart SER with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for SER.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 49.8%, and over 6 months it fell 15.2%. The month-end price fell 90.9% over the 3 years through Oct 2026, a compound annual decline of 55.1%.

    PeriodChange
    1 month-17.3%
    3 months-49.8%
    6 months-15.2%
    12 months-66.6%
    12 months, with dividends-66.6%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years-90.9%-55.1%
    5 years-93.3%-41.8%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2020, when the price fell 16.5%, and its weakest was 2024, when it fell 63.6%.

    YearCloseChange
    2026 through Oct 2026$1.94+1.4%
    2025$1.91-61.8%
    2024$5.01-63.6%
    2023$13.75-30.2%
    2022$19.71-49.4%
    2021$38.93-28.3%
    2020$54.29-16.5%
    2019$65.00-39.1%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 27.8% below its 50-day average of $1.89 and 32.0% below its 200-day average of $2.01.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$1.36
    52-week high$4.26-68.0%
    52-week low$1.14+19.7%
    50-day average$1.89-27.8%
    200-day average$2.01-32.0%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 94.3%.

    MeasureValue
    1-year beta1.27
    Largest fall, 1 year-70.0%
    Largest fall, 3 years-94.3%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About SER

    What is SER's 1-year price change?

    Serina Therapeutics's price fell 66.6% over the past 12 months. With dividends included, the 12-month total return was -66.6%.

    What is SER's 5-year price change?

    Serina Therapeutics's month-end price fell 93.3% over the 5 years through Oct 2026, a compound annual decline of 41.8%. These figures leave out dividends.

    What is SER's 52-week high and low?

    Serina Therapeutics's 52-week high is $4.26 and its 52-week low is $1.14. Its latest price of $1.36 on Nov 17, 2026 is 68.0% below the high.

    What is SER's beta?

    Serina Therapeutics's 1-year beta against the S&P 500 is 1.27, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 70.0%.

    Is the SER chart free?

    Yes. Advanced Charting for SER is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.